Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeBiotech

      Biotech

      Pendulum Therapeutics Appoints Madison Reed Founder and CEO Amy Errett to Board of Directors
      Biotech

      Pendulum Therapeutics Appoints Madison Reed Founder and CEO Amy Errett to Board of Directors

      June 26, 2026
      Rare Neurological Disease Treatment Market to Reach USD 43.7 Billion by 2036 as Orphan Drug Approvals and Genetic Diagnostics Expand Specialist Care | Future Market Insights
      Biotech

      Rare Neurological Disease Treatment Market to Reach USD 43.7 Billion by 2036 as Orphan Drug Approvals and Genetic Diagnostics Expand Specialist Care | Future Market Insights

      June 25, 2026
      WuXi Biologics’ 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations
      Biotech

      WuXi Biologics’ 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations

      June 24, 2026
      PleoPharma, Inc. to Present at BIO International Convention 2026
      Biotech

      PleoPharma, Inc. to Present at BIO International Convention 2026

      June 23, 2026
      Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
      Biotech

      Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits

      June 22, 2026
      CureGene Achieves First Participant Dosed in U.S. Pivotal Trial for Evategrel (CG-0255), a Best-in-Class Antiplatelet Drug, Accelerating Global Commercialization
      Biotech

      CureGene Achieves First Participant Dosed in U.S. Pivotal Trial for Evategrel (CG-0255), a Best-in-Class Antiplatelet Drug, Accelerating Global Commercialization

      June 21, 2026
      SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters’ Option to Purchase Additional Shares
      Biotech

      SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters’ Option to Purchase Additional Shares

      June 20, 2026
      Deck Bio to Present Multi-pMHC T Cell Engager Platform at the 8th T-Cell Engager Therapeutics Summit and BIO 2026
      Biotech

      Deck Bio to Present Multi-pMHC T Cell Engager Platform at the 8th T-Cell Engager Therapeutics Summit and BIO 2026

      June 19, 2026
      ZYUS Life Sciences Corporation Announces Closing of Third Tranche of Secured Loan Financing
      Biotech

      ZYUS Life Sciences Corporation Announces Closing of Third Tranche of Secured Loan Financing

      June 18, 2026
      SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
      Biotech

      SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares

      June 17, 2026
      « 1 … 17 18 19 20 21 … 212 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026